Abstract Library

#2242 Diagnostic Utility of Ki-67 as a Mean to Predict the Uptake of Functional Imaging Modalities in Patients with Neuroendocrine Neoplasms

Introduction: Functional imaging with FDG-PET and somatostatin receptors scintigraphy (SRS), play a key role in the diagnosis, treatment and follow-up of patients with neuroendocrine neoplasms (NENs). The proliferative index, ki67, is a reliable pathological marker for grading.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Mavroeidi V

Authors: Liotsou T, Mavroeidi V, Alexandraki K, Stefanoyiannis A, Thomas D,

Keywords: SRS, PET-FDG, ki-67, NENs,

#2060 Peptide Receptor Radionuclide Therapy (PRRT) in 35 Patients with Metastatic Neuroendocrine Neoplasms (NENs): Overall Response and Toxicity

Introduction: Metastatic or inoperable NeuroEndocrine Neoplasms (NENs) are unresponsive to chemotherapy and targeted therapies. An emerging option is PRRT.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Liotsou T

Authors: Liotsou T, Stefanoyiannis A, Alexandraki K, Koumarianou A, Angelousi A,

Keywords: NENs, PRRT,

#757 Circulating Endothelial Cells in Neuroendocrine Tumors

Introduction: Circulating endothelial cells (CECs) are mature endothelial cells that are shed into the bloodstream. We hypothesised that neuroendocrine tumors (NETs), being highly vascular, may shed more CECs into the circulation, and that changes in their number may serve as a biomarker for anti-angiogenic therapy.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Mandair D, Khan M, Lowe H, Griffin N, Tsigani T,

Keywords: biomarker,

#553 Neuroendocrine and Ductal Breast Cancer Coexistence: An Unusual Case Report

Introduction: Breast Primary Neuroendocrine carcinoma (BNEC) is a rare entity. Literature surveillance reveal few cases with no well-established therapeutic options. We herein report a case.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Vaslamatzis M, Alevizopoulos N, Laskarakis A, Theodora K, Mpallasis K,

Keywords: breast, NET, endocrine,

#250 Circulating Tumor Cells (CTCs) Correlate with Overall Survival in Neuroendocrine Tumors (NETs)

Introduction: Using the CellSearchTM system, circulating tumor cells (CTCs) can be reproducibly enumerated. We have previously shown that CTCs are detectable in NETs and associated with progressive disease.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Khan M, Tsigani T, Garcia-Hernandez J, Caplin M, Meyer T,

Keywords: neuroendocrine tumor, circulating tumor cells, carcinoid, survival,